Clinical trials recruiting for Endometrioid Ovarian Cancer
Fewer than 3 recruiting trials found.
2
Recruiting trials
1
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Biological NI-1801 | 1 |
| Cirtuvivint | 1 |
| NI-1801 in combination with anti-PD1 (Pembrolizumab) | 1 |
| NI-1801 in combination with paclitaxel | 1 |
| Olaparib | 1 |
| Paclitaxel | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Colorado | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers
- Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer
Related conditions
Trials recruiting for Endometrioid Ovarian Cancer often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Triple-negative breast cancer 138Primary Peritoneal Cancer 6Pancreatic cancer 870Non-squamous Non-small-cell Lung Cancer 11Lung cancer 2180Fallopian Tube Cancer 10Epithelial Ovarian Cancer 10
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Endometrioid Ovarian Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.